Peptide Powder Melanotan-2 Melanotan II

Melanotan II requiere una dosificación acumulativa para ser eficaz. Dependiendo del individuo, La dosis acumulativa necesaria normalmente será de 10 a 40 mg, Las personas más justas generalmente exigen cantidades en el extremo superior del rango.. Dependiendo de la cantidad total necesaria y de la dosis diaria adecuada para el individuo, Las inyecciones de MT-II deberán comenzar al menos una semana antes de que sea necesario mejorar el bronceado.. Más típicamente, MT-II use should begin at least a month prior to such need.Melanotan II can also be used on a cycled basis to maintain improved ability to tan.Further, Melanotan II se puede utilizar ocasionalmente para lograr un efecto prosexual..

Melanotan-1, the precusor to Melanotan II, would eventually be licensed for commercialization as a tanning agent and has been in development for use as a potential “therapeutic tan,” with minimal need for prolonged sun exposure. In the initial clinical testing of Melanotan II, an immediate and unexpected response was noted. The main subject experienced an erection shortly after administration. It was suggested that Melanotan II “may prove equally effective in women” as a “treatment of female sexual dysfunction. At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further “investigation of centrally acting agents on disorders of sexual desire.
Theoretically, Melanotan II may enhance sexual function in males (erectile activity) and females (increased levels of sexual desire and genital arousal). Unlike other sexual-enhancement drugs, it is hypothesizedd that Melanotan II works at a neurological level, eliciting a more “natural” sexual response with minimal side effects. It was suggested that Melanotan II “may prove equally effective in women” as a “treatment of female sexual dysfunction.[5] At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further “investigation of centrally acting agents on disorders of sexual desire.